| Medical and Health Sciences | Lifetime | 241 | IT 10 | 99.99 |
| Mathematics and Statistics | Lifetime | 834 | IT 17 | 98.78 |
| Medical and Health Sciences | 2021-2025 | 139 | IT 11 | 99.97 |
| Mathematics and Statistics | 2021-2025 | 421 | IT 9 | 96.11 |
| Medical Physiology | Lifetime | 102 | IT 1 | 99.84 |
| Infectious Diseases | Lifetime | 74 | IT 3 | 99.76 |
| Surgery | Lifetime | 379 | IT 16 | 99.68 |
| Epidemiology | Lifetime | 299 | IT 12 | 99.62 |
| Hematology | Lifetime | 71 | IT 6 | 99.58 |
| Statistics, Probability and Uncertainty | Lifetime | 70 | IT 3 | 99.30 |
| Cardiology and Cardiovascular Medicine | Lifetime | 316 | IT 17 | 99.59 |
| Internal Medicine | Lifetime | 34 | IT 3 | 99.32 |
| Oncology | Lifetime | 412 | IT 17 | 99.29 |
| Pulmonary and Respiratory Medicine | Lifetime | 562 | IT 21 | 99.20 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 489 | IT 29 | 98.54 |
| Clinical Neurology | Lifetime | 454 | IT 16 | 98.08 |
| Medical Genetics | Lifetime | 364 | IT 28 | 96.92 |
| Nephrology | Lifetime | 310 | IT 15 | 97.43 |
| Pathology and Forensic Medicine | Lifetime | 678 | IT 26 | 96.93 |
| Complementary and Alternative Medicine | Lifetime | 591 | IT 12 | 95.67 |
| Cancer Research | Lifetime | 696 | IT 19 | 95.22 |
| Clinical Biochemistry | Lifetime | 273 | IT 10 | 95.24 |
| Emergency Medicine | Lifetime | 527 | IT 11 | 95.11 |
| Rehabilitation | Lifetime | 403 | IT 6 | 94.51 |
| Critical Care and Intensive Care Medicine | Lifetime | 357 | IT 15 | 92.17 |
| Family Practice | Lifetime | 173 | IT 2 | 88.04 |
| Medical Biochemistry | Lifetime | 418 | IT 16 | 87.98 |
| Orthopedics and Sports Medicine | Lifetime | 955 | IT 22 | 84.54 |
| Modeling and Simulation | Lifetime | 551 | IT 20 | 76.29 |
| Infectious Diseases | 2021-2025 | 13 | IT 2 | 99.81 |
| Clinical Neurology | 2021-2025 | 60 | IT 6 | 98.79 |
| Medical Physiology | 2021-2025 | 134 | IT 8 | 98.43 |
| Surgery | 2021-2025 | 247 | IT 17 | 98.44 |
| Internal Medicine | 2021-2025 | 26 | IT 2 | 97.16 |
| Oncology | 2021-2025 | 306 | IT 20 | 97.20 |
| Epidemiology | 2021-2025 | 449 | IT 22 | 96.12 |
| Molecular Biology | 2021-2025 | 928 | IT 21 | 94.75 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 425 | IT 23 | 94.60 |
| Hematology | 2021-2025 | 177 | IT 13 | 94.57 |
| Statistics, Probability and Uncertainty | 2021-2025 | 116 | IT 5 | 93.56 |
| Public, Environmental and Occupational Health | 2021-2025 | 966 | IT 32 | 89.98 |
| Health | 2021-2025 | 340 | IT 5 | 89.50 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 814 | IT 46 | 89.29 |
| Immunology | 2021-2025 | 507 | IT 18 | 85.60 |
| Critical Care and Intensive Care Medicine | 2021-2025 | 141 | IT 12 | 84.51 |
| Emergency Medicine | 2021-2025 | 245 | IT 10 | 84.72 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 704 | IT 34 | 83.84 |
| Health Informatics | 2021-2025 | 185 | IT 2 | 74.74 |
| Rheumatology | 2021-2025 | 474 | IT 31 | 74.80 |
| Cancer Research | 2021-2025 | 416 | IT 9 | 69.65 |
| Modeling and Simulation | 2021-2025 | 339 | IT 13 | 68.72 |
| Pathology and Forensic Medicine | 2021-2025 | 549 | IT 26 | 68.32 |
| Clinical Pharmacology | 2021-2025 | 546 | IT 13 | 61.49 |
| Long-Term Effects of COVID-19 | Lifetime | 2 | IT 2 | 99.91 |
| COVID-19 Clinical Research Studies | Lifetime | 7 | IT 1 | 99.94 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 2 | IT 2 | 99.86 |
| COVID-19 and healthcare impacts | Lifetime | 6 | IT 2 | 99.83 |
| Clinical Laboratory Practices and Quality Control | Lifetime | 1 | IT 1 | 99.93 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 14 | IT 2 | 99.89 |
| SARS-CoV-2 detection and testing | Lifetime | 3 | IT 1 | 99.86 |
| Blood properties and coagulation | Lifetime | 6 | IT 1 | 99.73 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 22 | IT 2 | 99.86 |
| Blood groups and transfusion | Lifetime | 17 | IT 2 | 99.54 |
| Platelet Disorders and Treatments | Lifetime | 16 | IT 2 | 99.69 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 20 | IT 2 | 99.64 |
| COVID-19 and Mental Health | Lifetime | 41 | IT 1 | 99.35 |
| Hemodynamic Monitoring and Therapy | Lifetime | 33 | IT 5 | 99.62 |
| Blood transfusion and management | Lifetime | 17 | IT 2 | 99.34 |
| Health and Medical Research Impacts | Lifetime | 17 | IT 2 | 99.00 |
| Hematological disorders and diagnostics | Lifetime | 26 | IT 3 | 99.31 |
| Biosimilars and Bioanalytical Methods | Lifetime | 23 | IT 2 | 99.20 |
| Hemophilia Treatment and Research | Lifetime | 20 | IT 4 | 99.31 |
| Sepsis Diagnosis and Treatment | Lifetime | 66 | IT 4 | 99.63 |
| Healthcare cost, quality, practices | Lifetime | 33 | IT 3 | 99.08 |
| Bacterial Identification and Susceptibility Testing | Lifetime | 69 | IT 2 | 99.52 |
| Biomedical and Engineering Education | Lifetime | 24 | IT 2 | 97.83 |
| Cardiovascular Effects of Exercise | Lifetime | 82 | IT 7 | 99.40 |
| Meta-analysis and systematic reviews | Lifetime | 32 | IT 3 | 99.45 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 194 | IT 11 | 99.44 |
| Hemostasis and retained surgical items | Lifetime | 12 | IT 4 | 99.03 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 27 | IT 2 | 99.03 |
| Acute Myocardial Infarction Research | Lifetime | 159 | IT 7 | 99.48 |
| Erythropoietin and Anemia Treatment | Lifetime | 49 | IT 6 | 98.93 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 185 | IT 5 | 99.05 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 112 | IT 12 | 98.71 |
| Muscle and Compartmental Disorders | Lifetime | 45 | IT 4 | 98.88 |
| Clinical Reasoning and Diagnostic Skills | Lifetime | 51 | IT 2 | 98.35 |
| Exercise and Physiological Responses | Lifetime | 115 | IT 2 | 98.73 |
| Muscle metabolism and nutrition | Lifetime | 188 | IT 3 | 98.85 |
| Reliability and Agreement in Measurement | Lifetime | 9 | IT 1 | 98.81 |
| Hemoglobinopathies and Related Disorders | Lifetime | 247 | IT 28 | 98.28 |
| Lipoproteins and Cardiovascular Health | Lifetime | 329 | IT 7 | 98.57 |
| Renal function and acid-base balance | Lifetime | 175 | IT 5 | 97.77 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | Lifetime | 146 | IT 5 | 98.14 |
| COVID-19 diagnosis using AI | Lifetime | 160 | IT 3 | 96.58 |
| COVID-19 Impact on Reproduction | Lifetime | 141 | IT 9 | 96.24 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 894 | IT 33 | 98.02 |
| High Altitude and Hypoxia | Lifetime | 189 | IT 7 | 97.14 |
| Vitamin C and Antioxidants Research | Lifetime | 204 | IT 8 | 97.22 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 480 | IT 48 | 97.85 |
| Heart Failure Treatment and Management | Lifetime | 626 | IT 32 | 97.75 |
| Cancer, Lipids, and Metabolism | Lifetime | 823 | IT 26 | 97.15 |
| Cardiovascular Disease and Adiposity | Lifetime | 642 | IT 30 | 96.93 |
| Hormonal and reproductive studies | Lifetime | 649 | IT 44 | 97.06 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 273 | IT 12 | 96.55 |
| Central Venous Catheters and Hemodialysis | Lifetime | 505 | IT 24 | 96.61 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 778 | IT 31 | 97.52 |
| Iron Metabolism and Disorders | Lifetime | 610 | IT 41 | 96.61 |
| Pancreatitis Pathology and Treatment | Lifetime | 865 | IT 63 | 96.74 |
| Vitamin D Research Studies | Lifetime | 510 | IT 18 | 96.62 |
| Blood disorders and treatments | Lifetime | 360 | IT 21 | 95.94 |
| Cardiovascular and exercise physiology | Lifetime | 782 | IT 33 | 97.02 |
| Dialysis and Renal Disease Management | Lifetime | 687 | IT 33 | 97.08 |
| COVID-19 epidemiological studies | Lifetime | 648 | IT 19 | 96.01 |
| Body Composition Measurement Techniques | Lifetime | 392 | IT 24 | 96.41 |
| Climate Change and Health Impacts | Lifetime | 850 | IT 21 | 95.13 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 274 | IT 21 | 94.66 |
| Neonatal Health and Biochemistry | Lifetime | 840 | IT 41 | 95.07 |
| Alcohol Consumption and Health Effects | Lifetime | 787 | IT 38 | 95.14 |
| Statistical Methods in Clinical Trials | Lifetime | 464 | IT 3 | 94.86 |
| Intramuscular injections and effects | Lifetime | 76 | IT 1 | 93.26 |
| Genetics and Physical Performance | Lifetime | 174 | IT 2 | 93.91 |
| Vitamin K Research Studies | Lifetime | 240 | IT 12 | 93.10 |
| Chronic Kidney Disease and Diabetes | Lifetime | 950 | IT 50 | 95.26 |
| Acute Kidney Injury Research | Lifetime | 754 | IT 45 | 93.67 |
| Migraine and Headache Studies | Lifetime | 625 | IT 99 | 93.85 |
| Dermatological and COVID-19 studies | Lifetime | 182 | IT 23 | 91.27 |
| Biomarkers in Disease Mechanisms | Lifetime | 324 | IT 48 | 90.17 |
| Quality and Safety in Healthcare | Lifetime | 298 | IT 14 | 92.55 |
| Ethics in Clinical Research | Lifetime | 710 | IT 7 | 91.51 |
| Data-Driven Disease Surveillance | Lifetime | 437 | IT 12 | 91.84 |
| GDF15 and Related Biomarkers | Lifetime | 240 | IT 9 | 89.01 |
| Potassium and Related Disorders | Lifetime | 450 | IT 21 | 92.13 |
| Doping in Sports | Lifetime | 126 | IT 3 | 91.31 |
| Thermal Regulation in Medicine | Lifetime | 817 | IT 20 | 89.85 |
| Neonatal and Maternal Infections | Lifetime | 754 | IT 34 | 90.78 |
| Coffee research and impacts | Lifetime | 702 | IT 36 | 86.33 |
| Travel-related health issues | Lifetime | 987 | IT 14 | 77.40 |
| Statistical Methods in Epidemiology | Lifetime | 127 | IT 1 | 47.07 |
| COVID-19 Clinical Research Studies | 2021-2025 | 11 | IT 2 | 99.88 |
| Long-Term Effects of COVID-19 | 2021-2025 | 15 | IT 2 | 99.64 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 39 | IT 1 | 99.73 |
| SARS-CoV-2 detection and testing | 2021-2025 | 12 | IT 1 | 99.37 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 26 | IT 2 | 99.46 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 3 | IT 1 | 99.14 |
| COVID-19 and healthcare impacts | 2021-2025 | 40 | IT 4 | 98.61 |
| Platelet Disorders and Treatments | 2021-2025 | 21 | IT 3 | 98.74 |
| Clinical Laboratory Practices and Quality Control | 2021-2025 | 4 | IT 2 | 99.09 |
| Inflammatory Biomarkers in Disease Prognosis | 2021-2025 | 42 | IT 3 | 95.39 |
| COVID-19 and Mental Health | 2021-2025 | 337 | IT 21 | 96.73 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 179 | IT 11 | 96.89 |
| Intramuscular injections and effects | 2021-2025 | 6 | IT 1 | 96.75 |
| Dermatological and COVID-19 studies | 2021-2025 | 22 | IT 11 | 93.37 |
| Healthcare cost, quality, practices | 2021-2025 | 75 | IT 3 | 93.96 |
| Biomedical and Engineering Education | 2021-2025 | 50 | IT 1 | 91.00 |
| COVID-19 diagnosis using AI | 2021-2025 | 312 | IT 7 | 93.22 |
| Biosensors and Analytical Detection | 2021-2025 | 597 | IT 8 | 93.31 |
| Bacillus and Francisella bacterial research | 2021-2025 | 145 | IT 18 | 88.08 |
| Acute Myocardial Infarction Research | 2021-2025 | 815 | IT 81 | 91.00 |
| Thermal Regulation in Medicine | 2021-2025 | 143 | IT 14 | 83.24 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 205 | IT 19 | 88.18 |
| Meta-analysis and systematic reviews | 2021-2025 | 265 | IT 6 | 87.97 |
| Influenza Virus Research Studies | 2021-2025 | 831 | IT 40 | 86.13 |
| Blood properties and coagulation | 2021-2025 | 194 | IT 8 | 82.65 |
| Blood transfusion and management | 2021-2025 | 262 | IT 3 | 81.85 |
| Bacterial Identification and Susceptibility Testing | 2021-2025 | 812 | IT 44 | 81.95 |
| Complement system in diseases | 2021-2025 | 528 | IT 42 | 78.40 |
| Hematological disorders and diagnostics | 2021-2025 | 245 | IT 25 | 74.74 |
| Blood disorders and treatments | 2021-2025 | 635 | IT 69 | 66.81 |
| Neonatal and Maternal Infections | 2021-2025 | 621 | IT 38 | 65.63 |
| Renal function and acid-base balance | 2021-2025 | 589 | IT 30 | 59.83 |
| Reliability and Agreement in Measurement | 2021-2025 | 70 | IT 5 | 59.23 |
| Parvovirus B19 Infection Studies | 2021-2025 | 825 | IT 88 | 56.41 |